96PPreliminary pharmacokinetic results from a phase I study of GBR 1302 in patients with HER2 positive cancers
Gudi, G, Ca, V, Gn, S, von Gunten, C, Fluhler, E, Back, JVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy487.027
Date:
December, 2018
File:
PDF, 79 KB
2018